Stimulation of Cytokine Production in Human Peripheral Blood Mononuclear Cells by an Aqueous Chlorella Extract

 

 Buy Article Permissions and Reprints

Abstract

CPE is an aqueous extract of the edible micro alga Chlorella pyrenoidosa, which has been shown to have immunostimulatory effects in vivo. In the present study, CPE was evaluated for an ability to stimulate cytokine production by human peripheral blood mononuclear cells (PBMC). PBMC from healthy individuals were treated ex vivo for 24 hours with 1, 10 and 100 μg/mL CPE. This resulted in a marked increase in the level of IL-10, a regulatory cytokine, and strong stimulation of the T-helper-1 (Th1) cell cytokines, IFN-γ and TNF-α. In contrast, stimulation of representative T-helper-2 (Th2) cell cytokines, IL-4 and IL-13, was minor. CPE (1, 10 or 100 μg/mL) did not cause a proliferation of human PBMC suggesting that enhanced secretion of cytokines was not secondary to an increase in cell number. We conclude that CPE stimulation of human PBMC induces a Th1-patterned cytokine response and a strong anti-inflammatory regulatory cytokine response, observations that await confirmation in vivo.

References

• 1 Kessler E. Comparative physiology and biochemistry of Chlorella species as the basis for their taxonomy and for their utilization in research and biotechnology. In: Kumar HD, editor. Phycotalk.  Meerut: Rastogi and. Co;  1989 141-53.
  PubMedGoogle Scholar
• 2 Merchant R E, Andre C A. Dietary supplementation with Chlorella pyrenoidosa produces positive results in patients with cancer or suffering from certain chronic illnesses.  JANA. 2001;  4 31-8.
  PubMedGoogle Scholar
• 3 Konishi F, Tanaka K, Kumamoto S, Hasegawa T, Okuda M, Yano I. et al . Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice.  Cancer Immunol Immunother. 1990;  32 1-7.
  PubMedGoogle Scholar
• 4 Miyazawa Y, Murayama T, Ooya N, Wang L F, Tung Y C, Yamaguchi M. Immunomodulation by a unicellular green algae (Chlorella pyrenoidosa) in tumor bearing mice.  J Ethnopharmacol. 1988;  24 135-46.
  CrossrefPubMedGoogle Scholar
• 5 Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, Himeno K. et al . Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection.  Infect Immun. 1986;  53 267-71.
  PubMedGoogle Scholar
• 6 Umezawa I, Komiyama K, Shibukawa N, Mori M, Kojima Y. An acidic polysaccharide, Chlon A from Chlorella pyrenoidosa: 1. Physicochemical and biological properties.  Chemotherapy. 1982;  30 1041-6.
  PubMedGoogle Scholar
• 7 Hasegawa T, Kimura Y, Hiromatsu K, Kobayashi N, Yamada A, Makino M. et al . Effect of hot water extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes .  Immunopharmacology. 1997;  35 273-82.
  CrossrefPubMedGoogle Scholar
• 8 Pugh N, Ross S A, ElSohly N H, ElSohly M A, Pasco D S. Isolation of three molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina vulgaris, Aphanizomenon flos-aque and Chlorella pyrenoidosa .  Planta Med. 2001;  67 737-42.
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Hasegawa T, Ito K, Ueno S, Kumamoto S, Ando Y, Yamada A. et al . Oral administration of hot water extracts of Chlorella vulgaris reduces IgE production against milk casein in mice.  Int J Immunopharmacol. 1999;  21 311-23.
  CrossrefPubMedGoogle Scholar
• 10 Halperin S A, Smith B, Nolan C, Shay J, Kralovec J. Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.  CMAJ. 2003;  169 111-7.
  PubMedGoogle Scholar
• 11 Kralovec J A, Metera K, Kumar J R, Watson L V, Girouard G S, Guan Y. et al . Immunostimulatory principles from Chlorella pyrenoidosa - Part 1: Isolation and biological assessment in vitro.  Phytomedicine. 2007;  14 57-64.
  CrossrefPubMedGoogle Scholar
• 12 Kralovec J A, Power M R, Liu F, Maydanski E, Ewart H S, Watson L V. et al . An aqueous Chlorella extract inhibits IL-5 production by mast cells in vitro and reduces ovalbumin-induced eosinophil infiltration in the airway in mice in vivo .  Int Immunopharmacol. 2005;  5 689-98.
  CrossrefPubMedGoogle Scholar
• 13 Reyes Suarez E, Kralovec J, Noseda M D, Ewart H S, Barrow C J, Lumsden M D. et al . Isolation, characterization and structural determination of a unique type of arabinogalactan from a immunostimulatory extract of Chlorella pyrenoidosa .  Carbohydr Res. 2005;  340 1489-98.
  PubMedGoogle Scholar
• 14 Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K. Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes.  Cancer Immunol Immunother. 1985;  19 73-8.
  PubMedGoogle Scholar
• 15 Armstrong P B, Armstrong M T, Pardy R L, Child A, Wainwright N. Immunohistochemical demonstration of a lipopolysaccharide in the cell wall of a eukaryote, the green alga, Chlorella .  Biol Bull. 2002;  203 203-4.
  CrossrefPubMedGoogle Scholar
• 16 Fillatreau S, Sweenie C H, McGeachy M J, Gray D, Anderton S M. B cells regulate autoimmunity by provision of IL-10.  Nat Immunol. 2002;  3 944-50.
  CrossrefPubMedGoogle Scholar
• 17 Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A. et al . Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors.  Infect Immun. 2000;  68 6883-90.
  CrossrefPubMedGoogle Scholar
• 18 Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.  Altern Med Rev. 2003;  8 223-46.
  PubMedGoogle Scholar
• 19 Goodin D S, Frohman E M, Garmany J, Halper J, Likosky W H, Lublin F D. et al . Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.  Neurology. 2002;  58 169-78.
  CrossrefPubMedGoogle Scholar
• 20 Lipsky P E, van der Heijde D M, Furst D E, Breedveld F C, Kalden J R. Infliximab and methotrexate in the treatment of rheumatoid arthritis.  N Engl J Med. 2000;  343 1594-602.
  CrossrefPubMedGoogle Scholar
• 21 Rapoport M J, Jaramillo A, Zipris D, Lazarus A H, Serreze D V, Leiter E H. et al . Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.  J Exp Med. 1993;  178 87-99.
  CrossrefPubMedGoogle Scholar
• 22 Hofstetter C, Flondor M, Hoegl S, Muhl H, Zwissler B. Interleukin-10 aerosol reduces proinflammatory mediators in bronchoalveolar fluid of endotoxemic rat.  Crit Care Med. 2005;  33 2317-22.
  CrossrefPubMedGoogle Scholar
• 23 Hess P J, Seeger J M, Huber T S, Welborn M B, Martin T D, Harward T RS. et al . Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia.  J Vasc Surg. 1997;  26 113-8.
  CrossrefPubMedGoogle Scholar
• 24 Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H. et al . IL-10 is a key cytokine in psoriasis . Proof of principle by IL-10 therapy: A new therapeutic approach.  J Clin Invest. 1998;  101 783-94.
  CrossrefPubMedGoogle Scholar
• 25 Chabot S, Williams G, Hamilton M, Sutherland G, Yong V W. Mechanisms of IL-10 production in human microglia-T cell interaction.  J Immunol. 1999;  162 6819-28.
  PubMedGoogle Scholar
• 26 Roon J AG van, Wijngaarden S, Lafeber F PJG, Damen C, van de Winkel J GJ, Bijlsma J WJ. Interleukin 10 treatment of patients with RA enhances Fcg receptor expression on monocytes and responsiveness to immune complex stimulation.  J Rheumatol. 2003;  30 648-51.
  PubMedGoogle Scholar

Dr. H. Stephen Ewart

Ocean Nutrition Canada Ltd.

101 Research Dr.

Dartmouth

NS B2Y 4T6

Canada

Phone: +1-902-480-3253

Fax: +1-902-480-3253

Email: sewart@ocean-nutrition.com

• Supplementary Material